DA Den Europæiske Unions Tidende C 8/7

Medicinske specialiteter — Liste over markedsføringstilladelser udstedt af EØS-EFTA-staterne i første halvdel af 2010

2011/C 8/07

Underudvalg I for frie varebevægelser

Til Det Blandede EØS-udvalgs underretning

Under henvisning til afgørelse truffet af Det Blandede EØS-udvalg nr. 74/1999 af 28. maj 1999 opfordres Det Blandede EØS-udvalg til på sit møde den 1. oktober 2010 at notere sig følgende lister over markedsføringstilladelser for medicinske specialiteter udstedt i perioden 1. januar-30. juni 2010:

Bilag I Liste over nye markedsføringstilladelser Bilag II Liste over fornyede markedsføringstilladelser Bilag III Liste over udvidede markedsføringstilladelser Bilag IV Liste over tilbagetrukne markedsføringstilladelser Bilag V Liste over suspenderede markedsføringstilladelser

BILAG I Liste over nye markedsføringstilladelser Følgende markedsføringstilladelser er blevet udstedt i EØS-EFTA-staterne i perioden 1. januar-30. juni 2010: EU-Nummer Produkt Land Udstedelsesdato EU/1/06/367/001/NO-012/NO Diacomit Norge 5.2.2010 EU/1/08/476/005-006 Adcirca Liechtenstein 28.2.2010 EU/1/09/571/001/IS Pandemisk influenzavaccine H5N1 Baxter Island 27.1.2010 EU/1/09/577/001/NO-004/NO Foclivia Norge 18.2.2010 EU/1/09/583/001/NO-072/NO Irbesartan/Hydrochlorothiazide Teva Norge 18.1.2010 EU/1/09/583/001-072 Irbesartan/Hydrochlorothiazide Teva Liechtenstein 28.2.2010 EU/1/09/584/001-018 Sildenafil Teva Liechtenstein 28.2.2010 EU/1/09/585/001/NO-018/NO Rivastigmine 1A Norge 9.3.2010 EU/1/09/585/001-018/IS Rivastigmine 1A Island 2.3.2010 EU/1/09/586/001/NO-010/NO Oslif Breezhaler Norge 27.1.2010 EU/1/09/586/001-010 Oslif Breezhaler Liechtenstein 28.2.2010 EU/1/09/587/001/NO-017/NO Olanzapine Glenmark Norge 3.2.2010 EU/1/09/587/001-017 Olanzapine Glenmark Liechtenstein 28.2.2010 EU/1/09/587/001-017/IS Olanzapine Glenmark Island 25.1.2010 EU/1/09/588/001/NO-012/NO Olanzapine Glenmark Europe Norge 6.2.2010 EU/1/09/588/001-012 Olanzapine Glenmark Europe Liechtenstein 28.2.2010 EU/1/09/588/001-012/IS Olanzapine Glenmark Europe Island 25.1.2010 EU/1/09/589/001/NO-018/NO Rivastigmine Hexal Norge 9.3.2010 EU/1/09/589/001-018 Rivastigmine Hexal Liechtenstein 28.2.2010 EU/1/09/589/001-018/IS Rivastigmine Hexal Island 4.3.2010 EU/1/09/590/001/NO-006/NO Prevenar 13 Norge 18.1.2010 EU/1/09/590/001-006 Prevenar 13 Liechtenstein 28.2.2010 EU/1/09/592/001/NO-005/NO Olazax Disperzi Norge 4.2.2010 EU/1/09/592/001-005 Olazax Disperzi Liechtenstein 28.2.2010 EU/1/09/592/001-005/IS Olazax Disperzi Island 25.1.2010 EU/1/09/593/001/NO-010/NO Onbrez Breezhaler Norge 6.1.2010 EU/1/09/593/001-010 Onbrez Breezhaler Liechtenstein 28.2.2010 EU/1/09/594/001/NO-010/NO Hirobriz Breezhaler Norge 28.1.2010 EU/1/09/594/001-010 Hirobriz Breezhaler Liechtenstein 28.2.2010 EU/1/09/595/001/NO-015/NO Sildenafil Actavis Norge 13.1.2010 EU/1/09/595/001-015/IS Sildenafil Actavis Island 7.1.2010 EU/1/09/596/001/NO-014/NO Lamuvidine Teva Pharma BV Norge 11.1.2010 EU/1/09/596/001-014 Lamivudine Teva Pharma BV Liechtenstein 28.2.2010 EU/1/09/596/001-014/IS Lamivudine Teva Pharma BV Island 1.3.2010 EU/1/09/597/001/NO-005/NO Olazax Norge 4.2.2010 EU/1/09/597/001-005/IS Olazax Island 25.1.2010 EU/1/09/598/001/NO-004/NO Nevirapine Teva Norge 11.1.2010 EU/1/09/598/001-004/IS Nevirapine Teva Island 1.3.2010 EU/1/09/599/001/NO-018/NO Rivastigmine Sandoz Norge 9.3.2010 EU/1/09/599/001-018/IS Rivastigmine Sandoz Island 4.3.2010 EU/1/09/600/001/IS Zutectra Island 24.2.2010 EU/1/09/600/001/NO Zutectra Norge 11.1.2010 EU/1/09/601/001 Zenas Liechtenstein 28.2.2010 EU/1/09/601/001/NO Zenas Norge 4.2.2010 EU/1/09/601/001/IS Zenas Island 20.1.2010 EU/1/09/602/001/NO-002/NO Scintimun Norge 25.1.2010 EU/1/09/602/001-002 Scintimun Liechtenstein 28.2.2010 EU/1/09/602/001-002/IS Scintimun Island 21.1.2010 EU/1/09/603/001/NO-012/NO Sildenafil ratiopharm Norge 13.1.2010 EU/1/09/603/001-012 Sildenafil ratiopharm Liechtenstein 28.2.2010 EU/1/09/603/001-012/IS Sildenafil ratiopharm Island 18.1.2010 EU/1/09/604/001/NO-010/NO Leflunomide Winthrop Norge 4.2.2010 EU/1/09/604/001-010 Leflunomide Winthrop Liechtenstein 28.2.2010 EU/1/09/604/001-010/IS Leflunomide Winthrop Island 22.1.2010 EU/1/09/605/001-012 Temomedac Liechtenstein 28.2.2010 EU/1/09/605/001-012/IS Temomedac Island 24.2.2010 EU/1/09/606/001/NO-012/NO Temozolomide Norge 15.2.2010 EU/1/09/606/001-012 Temozolomide Liechtenstein 28.2.2010 EU/1/09/606/001-012/IS Temozolomide Island 16.2.2010 EU/1/09/607/001/NO-014/NO Silodyx Norge 9.2.2010 EU/1/09/607/001-014 Silodyx Liechtenstein 28.2.2010 EU/1/09/607/001-014/IS Silodyx Island 16.3.2010 EU/1/09/608/001/NO-014/NO Urorec Norge 9.2.2010 EU/1/09/608/001-014 Urorec Liechtenstein 28.2.2010 EU/1/09/608/001-014/IS Urorec Island 16.3.2010 EU/1/09/609/001/NO-002/NO Elonva Norge 11.3.2010 EU/1/09/609/001-002 Elonva Liechtenstein 28.2.2010 EU/1/09/609/001-002/IS Elonva Island 10.2.2010 EU/1/09/610/001/NO-030/NO Telmisartan Teva Norge 2.3.2010 EU/1/09/610/001-030 Telmisartan Teva Liechtenstein 28.2.2010 EU/1/09/610/001-030/IS Telmisartan Teva Island 16.3.2010 EU/1/09/611/001/NO-002/NO Docetaxel Teva Norge 26.2.2010 EU/1/09/611/001-002 Docetaxel Teva Liechtenstein 28.2.2010 EU/1/09/611/001-002/IS Docetaxel Teva Island 23.2.2010 EU/1/10/612/001/NO-006/NO Revolade Norge 25.3.2010 EU/1/10/612/001-006 Revolade Liechtenstein 30.4.2010 EU/1/10/612/001-006/IS Revolade Island 7.4.2010 EU/1/10/613/001/NO-002/NO ImmunoGam Norge 19.4.2010 EU/1/10/613/001-002 ImmunoGam Liechtenstein 30.4.2010 EU/1/10/613/001-002/IS ImmunoGam Island 28.4.2010 EU/1/10/614/001 Menveo Liechtenstein 30.4.2010 EU/1/10/614/001/IS Menveo Island 15.6.2010 EU/1/10/614/001/NO Menveo Norge 21.4.2010 EU/1/10/615/001/NO-024/NO Temozolomide Hospira Norge 24.3.2010 EU/1/10/615/001-024 Temozolomide Hospira Liechtenstein 30.4.2010 EU/1/10/615/001-024/IS Temozolomide Hospira Island 3.5.2010 EU/1/10/616/001/NO-024/NO Temozolomide Hexal Norge 26.4.2010 EU/1/10/616/001-024 Temozolomide Hexal Liechtenstein 30.4.2010 EU/1/10/616/001-024/IS Temozolomide Hexal Island 27.4.2010 EU/1/10/617/001/NO-024/NO Temozolomide Sandoz Norge 26.4.2010 EU/1/10/617/001-024 Temozolomide Sandoz Liechtenstein 30.4.2010 EU/1/10/617/001-024/IS Temozolomide Sandoz Island 27.4.2010 EU/1/10/618/001-004 Prolia Liechtenstein 30.6.2010 EU/1/10/618/001-004/IS Prolia Island 23.6.2010 EU/1/10/619/001/NO-014/NO DuoPlavin Norge 23.3.2010 EU/1/10/619/001-014 DuoPlavin Liechtenstein 30.4.2010 EU/1/10/619/001-014/IS DuoPlavin Island 21.4.2010 EU/1/10/620/001/NO-016/NO Ristfor Norge 3.6.2010 EU/1/10/620/001-016 Ristfor Liechtenstein 30.4.2010 EU/1/10/620/001-016/IS Ristfor Island 5.5.2010 EU/1/10/621/001/NO-018/NO Ristaben Norge 3.6.2010 EU/1/10/621/001-018 Ristaben Liechtenstein 30.4.2010 EU/1/10/621/001-018/IS Ristaben Island 5.5.2010 EU/1/10/622/001/NO-002/NO Tepadina Norge 25.3.2010 EU/1/10/622/001-002/IS Tepadina Island 21.4.2010 EU/1/10/622/001-002 Tepadina Liechtenstein 30.4.2010 EU/1/10/623/001/NO-014/NO DuoCover Norge 23.3.2010 EU/1/10/623/001-014 DuoCover Liechtenstein 30.4.2010 EU/1/10/623/001-014/IS DuoCover Island 21.4.2010 EU/1/10/624/001 Arepanrix Liechtenstein 30.4.2010 EU/1/10/624/001/IS Arepanrix Island 21.5.2010 EU/1/10/625/001/NO-002/NO Arzerra Norge 12.5.2010 EU/1/10/625/001-002 Arzerra Liechtenstein 30.4.2010 EU/1/10/625/001-002/IS Arzerra Island 17.5.2010 EU/1/10/626/001/NO-004/NO Ribavirin BioPartners Norge 22.4.2010 EU/1/10/626/001-004/IS Ribavirin BioPartners Island 17.5.2010 EU/1/10/627/001/NO-003/NO Raloxifene Teva Norge 31.5.2010 EU/1/10/627/001-003 Raloxifene Teva Liechtenstein 30.4.2010 EU/1/10/627/001-003/IS Raloxifene Teva Island 18.6.2010 EU/1/10/628/001/NO-004/NO Votrient Norge 28.6.2010 EU/1/10/628/001-004 Votrient Liechtenstein 30.6.2010 EU/1/10/628/001-004/IS Votrient Island 28.6.2010 EU/1/10/629/001 Humenza Liechtenstein 30.6.2010 EU/1/10/629/001/IS Humenza Island 28.6.2010 EU/1/10/630/001/NO-002/NO Docefrez Norge 7.6.2010 EU/1/10/630/001-002 Docefrez Liechtenstein 30.6.2010 EU/1/10/630/001-002/IS Docefrez Island 29.6.2010 EU/1/10/631/001-009 Nivestim Liechtenstein 30.6.2010 EU/1/10/632/001-021 Tolura Liechtenstein 30.6.2010 EU/1/10/633/001/NO-002/NO Topotecan Hospira Norge 22.6.2010 EU/1/10/633/001-002 Topotecan Hospira Liechtenstein 30.6.2010 EU/1/10/634/001-004 Ribaverin Three Rivers Liechtenstein 30.6.2010 EU/1/10/634/001-004/IS Ribavirin Three Rivers Island 28.6.2010 EU/1/10/635/001-014 Olanzapine Apotex Liechtenstein 30.6.2010 EU/1/10/635/001-014/IS Olanzapine Apotex Island 28.6.2010 EU/2/08/085/001/NO Easotic Norge 4.5.2010 EU/2/08/090/001-008/IS Loxicom Island 23.2.2010 EU/2/09/096/001/NO-002/NO Leucogen Norge 8.2.2010 EU/2/09/101/001/NO-010/NO Zolvix Norge 8.2.2010 EU/2/09/101/001-010/IS Zolvix Island 4.3.2010 EU/2/09/102/001/NO-006/NO Gripovac 3 Norge 21.4.2010 EU/2/09/102/001-006 Gripovac 3 Liechtenstein 28.2.2010 EU/2/09/102/001-006/IS Gripovac 3 Island 4.3.2010 EU/2/09/103/001-006 Respiporc FLU3 Liechtenstein 28.2.2010 EU/2/09/103/001-006/IS Respiporc FLU3 Island 4.3.2010 EU/2/09/104/001/NO-002/NO Zulvac 8 Ovis Norge 11.2.2010 EU/2/09/104/001-002 Zulvac 8 Ovis Liechtenstein 28.2.2010 EU/2/09/104/001-002/IS Zulvac 8 Ovis Island 28.1.2010 EU/2/09/105/001/NO-002/NO Zulvac 8 Bovis Norge 8.2.2010 EU/2/09/105/001-002 Zulvac 8 Bovis Liechtenstein 28.2.2010 EU/2/09/105/001-002/IS Zulvac 8 Bovis Island 27.1.2010

BILAG II Liste over fornyede markedsføringstilladelser Følgende markedsføringstilladelser er blevet fornyet i EØS-EFTA-staterne i perioden 1. januar-30. juni 2010: EU-Nummer Produkt Land Udstedelsesdato EU/1/00/129/001-003 Azopt Liechtenstein 28.2.2010 EU/1/00/129/001-003/IS Azopt Island 16.3.2010 EU/1/00/130/001/NO-002/NO Orgalutran Norge 8.6.2010 EU/1/00/130/001-002 Orgalutran Liechtenstein 30.6.2010 EU/1/00/130/001-002/IS Orgalutran Island 25.6.2010 EU/1/00/131/001/NO-005/NO PegIntron Norge 26.5.2010 EU/1/00/131/001-050 PegIntron Liechtenstein 30.6.2010 EU/1/00/131/001-050/IS PegIntron Island 24.6.2010 EU/1/00/132/001/NO-050/NO ViraferonPeg Norge 26.5.2010 EU/1/00/132/001-050 ViraferonPeg Liechtenstein 30.6.2010 EU/1/00/132/001-050/IS ViraferonPeg Island 25.6.2010 EU/1/00/133/001/NO-032/NO Optisulin Norge 25.5.2010 EU/1/00/133/001-032 Optisulin Liechtenstein 30.6.2010 EU/1/00/133/001-032/IS Optisulin Island 25.6.2010 EU/1/00/134/001/NO-037/NO Lantus Norge 25.5.2010 EU/1/00/134/001-037 Lantus Liechtenstein 30.6.2010 EU/1/00/134/001-037/IS Lantus Island 25.6.2010 EU/1/00/137/002/NO-018/NO Avandia Norge 7.6.2010 EU/1/00/137/002-012/IS Avandia Island 18.6.2010 EU/1/00/137/002-018 Avandia Liechtenstein 30.6.2010 EU/1/00/140/001 Visudyne Liechtenstein 30.6.2010 EU/1/00/140/001/IS Visudyne Island 23.6.2010 EU/1/04/272/001/NO-002/NO PhotoBarr Norge 17.2.2010 EU/1/04/294/001-028 Emselex Liechtenstein 28.2.2010 EU/1/04/298/001/NO-003/NO Kivexa Norge 19.1.2010 EU/1/04/298/001-003 Kivexa Liechtenstein 28.2.2010 EU/1/04/299/001/NO-003/NO Fendrix Norge 3.2.2010 EU/1/04/299/001-003 Fendrix Liechtenstein 28.2.2010 EU/1/04/299/001-003/IS Fendrix Island 7.1.2010 EU/1/04/300/001/NO-002/NO Avastin Norge 26.1.2010 EU/1/04/300/001-002 Avastin Liechtenstein 28.2.2010 EU/1/04/300/001-002/IS Avastin Island 11.1.2010 EU/1/04/302/001/NO-004/NO Prialt Norge 8.2.2010 EU/1/04/302/001-004 Prialt Liechtenstein 28.2.2010 EU/1/04/302/001-004/IS Prialt Island 17.3.2010 EU/1/04/303/001/NO-003 Orfadin Norge 3.2.2010 EU/1/04/303/001-003 Orfadin Liechtenstein 28.2.2010 EU/1/04/303/001-003/IS Orfadin Island 28.1.2010 EU/1/04/304/001/NO-007/NO Azilect Norge 10.2.2010 EU/1/04/305/001/NO-002/NO Truvada Norge 3.2.2010 EU/1/04/305/001-002 Truveda Liechtenstein 28.2.2010 EU/1/04/305/001-002/IS Truvada Island 28.1.2010 EU/1/04/306/001 Aloxi Liechtenstein 30.4.2010 EU/1/04/306/001/IS Aloxi Island 11.5.2010 EU/1/04/306/01/NO Aloxi Norge 23.4.2010 EU/1/04/307/001/NO-013/NO Zonegran Norge 5.2.2010 EU/1/04/307/001-013 Zonegran Liechtenstein 28.2.2010 EU/1/04/307/001-013/IS Zonegran Island 13.1.2010 EU/1/05/308/001/NO-002/NO Aclasta Norge 23.4.2010 EU/1/05/308/001-002 Aclasta Liechtenstein 30.4.2010 EU/1/05/308/001-002/IS Aclasta Island 30.4.2010 EU/1/06/367/001-012 Diacomit Liechtenstein 28.2.2010 EU/1/07/423/001-003 Vectibix Liechtenstein 30.4.2010 EU/1/07/423/001-003/IS Vectibix Island 7.4.2010 EU/1/07/440/001-003/IS Tyverb Island 30.6.2010 EU/1/10/618/001/NO-004/NO Prolia Norge 14.6.2010 EU/1/99/122/001-002 Thyrogen Liechtenstein 28.2.2010 EU/1/99/122/001-002/IS Thyrogen Island 19.2.2010 EU/1/99/123/005/NO-013/NO Renagel Norge 14.1.2010 EU/1/99/123/005-013 Renagel Liechtenstein 28.2.2010 EU/1/99/123/005-013/IS Renagel Island 5.1.2010 EU/1/99/124/001/NO-002/NO Tractocile Norge 27.1.2010 EU/1/99/124/001-002 Tractocile Liechtenstein 28.2.2010 EU/1/99/124/001-002/IS Tractocile Island 18.1.2010 EU/1/99/126/001/NO-021/NO Enbrel Norge 14.1.2010 EU/1/99/127/011/NO-044/NO IntronA Norge 21.4.2010 EU/1/99/127/011-039 & 041-044/IS IntronA Island 19.4.2010 EU/1/99/127/011-044 IntronA Liechtenstein 30.4.2010 EU/2/00/018/001 Incurin Liechtenstein 30.4.2010 EU/2/00/018/001/IS Incurin Island 21.4.2010 EU/2/00/018/001/NO Incurin Norge 10.5.2010 EU/2/00/019/005/NO-007/NO Purevax FeLV Norge 10.5.2010 EU/2/00/019/005-007 Purevax FeLV Liechtenstein 30.4.2010 EU/2/00/019/005-007/IS Purevax FeLV Island 10.5.2010 EU/2/00/021/001-002 Rabigen SAG2 Liechtenstein 30.4.2010 EU/2/00/021/001-002/IS Rabigen SAG2 Island 5.5.2010 EU/2/00/022/001a-001b, EU/2/00/022/002a-002b, EU/2/00/022/003a-003b, EU/2/022/004a-004b, EU/2/00/022/005-017 Ibaflin Liechtenstein 30.6.2010 EU/2/00/022/003-004 a+b&007-008/IS Ibaflin Island 22.6.2010 EU/2/00/022/001-002 a+b&005-006/IS Ibaflin Island 22.6.2010 EU/2/00/22/009-017/IS Ibaflin Island 22.6.2010 EU/2/04/043/001/IS Equilis StrepE Island 14.4.2010 EU/2/04/047/001/NO-002/NO Purevax RCPCh FeLV Norge 24.2.2010 EU/2/04/047/001-002 Purevax RCPCh FeLV Liechtenstein 28.2.2010 EU/2/04/047/001-002/IS Purevax RCPCh FeLV Island 15.1.2010 EU/2/04/048/001-002 Purevax RCP FeLV Liechtenstein 28.2.2010 EU/2/04/048/001-002/IS Purevax RCP FeLV Island 9.2.2010 EU/2/04/049/001-002 Purevax RCCh Liechtenstein 28.2.2010 EU/2/04/049/001-002/IS Purevax RCCh Island 9.2.2010 EU/2/04/051/001-002 Purevax RC Liechtenstein 28.2.2010 EU/2/04/051/001-002/IS Purevax RC Island 9.2.2010 EU/2/04/052/001-002/IS Purevax RCP Island 9.2.2010 EU/2/04/50/001-002/IS Purevax RCPCh Island 8.2.2010 EU/2/05/053/001-003 Naxcel Liechtenstein 30.6.2010 EU/2/99/013/001/NO-002/NO Halocur Norge 26.4.2010 EU/2/99/013/001-002/IS Halocur Island 15.3.2010 EU/2/99/017/001/NO-006/NO Ibraxion Norge 11.5.2010 EU/2/99/017/001-006/IS Ibraxion Island 25.5.2010

BILAG III Liste over udvidede markedsføringstilladelser Følgende markedsføringstilladelser er blevet udvidet i EØS-EFTA-staterne i perioden 1. januar-30. juni 2010: EU-Nummer Produkt Land Udstedelses-dato EU/1/00/152/019-020 Infanrix hexa Liechtenstein 30.6.2010 EU/1/00/156/004 Trizivir Liechtenstein 30.6.2010 EU/1/01/172/007 Kaletra Liechtenstein 28.2.2010 EU/1/02/205/003/NO-004/NO Lumigan Norge 12.3.2010 EU/1/02/205/003-004 Lumigan Liechtenstein 28.2.2010 EU/1/02/205/003-004/IS Lumigan Island 21.1.2010 EU/1/04/278/010-011 Levemir Liechtenstein 30.4.2010 EU/1/04/306/002-003 Aloxi Liechtenstein 30.6.2010 EU/1/04/306/002-003/IS Aloxi Island 11.5.2010 EU/1/05/318/002 Revatio Liechtenstein 28.2.2010 EU/1/05/318/002/IS Revatio Island 14.1.2010 EU/1/05/318/002/NO Revatio Norge 18.1.2010 EU/1/05/329/006 Kiovig Liechtenstein 30.6.2010 EU/1/06/334/005 Evoltra Liechtenstein 28.2.2010 EU/1/06/360/013 Champix Liechtenstein 28.2.2010 EU/1/07/384/003/NO-004/NO Docetaxel Winthrop Norge 1.2.2010 EU/1/07/384/003-004 Docetaxel Winthrop Liechtenstein 28.2.2010 EU/1/07/384/005 Docetaxel Winthrop Liechtenstein 30.6.2010 EU/1/07/386/017-018 Toviaz Liechtenstein 28.2.2010 EU/1/07/400/022-024 Mircera Liechtenstein 30.4.2010 EU/1/07/405/021-040 Rasilez Liechtenstein 28.2.2010 EU/1/07/411/021-026/IS Epoetin alfa Hexal Island 3.2.2010 EU/1/07/412/021/NO-026/NO Abseamed Norge 13.1.2010 EU/1/07/412/021-026 Abseamed Liechtenstein 28.2.2010 EU/1/07/440/003 Tyverb Liechtenstein 30.6.2010 EU/1/08/444/009-012 Ratiograstim Liechtenstein 28.2.2010 EU/1/08/445/009-014 Tevagrastim Liechtenstein 28.2.2010 EU/1/08/450/009-010 Biograstim Liechtenstein 28.2.2010 EU/1/08/453/002/NO Prepandrix Norge 9.2.2010 EU/1/08/467/002 Doribax Liechtenstein 30.4.2010 EU/1/08/467/002/IS Doribax Island 15.6.2010 EU/1/08/494/003-004 Stelara Liechtenstein 30.4.2010 EU/1/08/497/005/NO-008/NO Nplate Norge 2.2.2010 EU/1/08/497/005-008 Nplate Liechtenstein 28.2.2010 EU/1/08/497/005-008/IS Nplate Island 22.1.2010 EU/1/09/508/010 Synflorix Liechtenstein 28.2.2010 EU/1/09/525/047-050 Nimvastid Liechtenstein 30.4.2010 EU/1/09/526/002 Iressa Liechtenstein 28.2.2010 EU/1/09/528/002 Nymusa Liechtenstein 30.6.2010 EU/1/09/538/007-008 Afinitor Liechtenstein 30.4.2010 EU/1/09/540/010-016 Clopidogrel Teva Liechtenstein 30.4.2010 EU/1/09/556/010-011 Clopidogrel Krka Liechtenstein 30.4.2010 EU/1/09/557/010 Clopidogrel Qualimed Liechtenstein 30.4.2010 EU/1/09/559/010-016 Clopidogrel Mylan Liechtenstein 30.4.2010 EU/1/95/002/003/NO-004/NO Taxotere Norge 25.1.2010 EU/1/95/002/003-004 Taxotere Liechtenstein 28.2.2010 EU/1/95/002/005 Taxotere Liechtenstein 30.6.2010 EU/1/96/016/005/NO-006/NO Norvir Norge 9.2.2010 EU/1/96/016/005-006 Norvir Liechtenstein 28.2.2010 EU/1/96/016/005-006/IS Norvir Island 12.2.2010 EU/1/97/050/028-033 Sifrol Liechtenstein 30.6.2010 EU/1/98/069/012 Plavix Liechtenstein 30.4.2010 EU/1/98/070/012 Iscover Liechtenstein 30.4.2010 EU/1/98/080/002 Aldara Liechtenstein 30.4.2010 EU/1/98/096/024-025 Temodal Liechtenstein 28.2.2010 EU/1/97/051/028-033 Mirapexin Liechtenstein 30.6.2010 EU/2/02/032/002 Vaxxitek HVT+IBD Liechtenstein 30.6.2010 EU/2/04/044/011/NO-013/NO Aivlosin Norge 29.4.2010 EU/2/04/044/011-013 Aivlosin Liechtenstein 28.2.2010 EU/2/04/044/011-013/IS Aivlosin Island 7.1.2010 EU/2/06/070/004/IS Meloxidyl Island 25.1.2010 EU/2/06/070/005-007 Meloxidyl Liechtenstein 30.4.2010 EU/2/08/083/002-003 Equioxx Liechtenstein 28.2.2010 EU/2/08/083/002-003/IS Equioxx Island 11.1.2010 EU/2/08/089/021 Onsior Liechtenstein 28.2.2010 EU/2/08/090/009 Loxicom Liechtenstein 30.4.2010 EU/2/97/004/035-038 Metacam Liechtenstein 28.2.2010

BILAG IV Liste over tilbagetrukne markedsføringstilladelser Følgende markedsføringstilladelser er blevet trukket tilbage i EØS-EFTA-staterne i perioden 1. januar-30. juni 2010: EU-Nummer Produkt Land Dato for inddragelsen EU/1/00/148/001-004 Agenerase Liechtenstein 30.6.2010 EU/1/00/148/001-004/IS Agenerase Island 29.6.2010 EU/1/06/375/001-033 Irbesartan BMS Liechtenstein 28.2.2010 EU/1/08/471/001-012/IS Duloxetine Boehringer Ingelheim Island 25.6.2010 EU/1/08/471/003-005, 011-012 Duloxetine Boehringer Ingelheim Liechtenstein 30.6.2010 EU/1/99/113/001-004 Paxene Liechtenstein 28.2.2010